Cognex officer Moschner proposes $1.61M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cognex Corporation director and officer Matthew Moschner gave notice of a proposed sale of 24,962 common shares, with an aggregate market value of $1,606,554.32 and an approximate sale date of August 11, 2026. The notice lists Nasdaq as the exchange.
The securities table lists 16,600 shares acquired through a cash exercise of stock options on August 11, 2026, and 8,362 restricted stock units acquired on February 20, 2025. The remarks describe the securities to be sold as acquired upon vesting of restricted stock units from February 20, 2025 through August 7, 2025. The notice identifies May 11, 2026 as the Rule 10b5-1 plan adoption or instruction date.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Units financial
Exercise of Stock Options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Rule 10b5-1 date is listed for Matthew Moschner's proposed CGNX sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.